Core Laboratories Inc.

CLB Energy Oil & Gas Equipment & Services

Core Laboratories Inc.’s revenue for fiscal 2025 (year ended December 2025) was $526.5 million, up 0.51% from fiscal 2024. In the quarter to June 2026, revenue fell 4.26%, EPS fell 43.5%, free cash flow fell 65.7% and total debt fell 8.63%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three; insiders bought in the last twelve months.

9.98 0.20 +2.04%
Market cap
$448.8M
P/E
19.2×
Fwd P/E
28.1×
Dividend yield
0.40%
F-score
7/9
Altman Z
3.29
Beneish M
−2.56
Dividend safety
82/100

Insider Decisions trades per month

Total buys 0.05
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — 1 — — —
Sell — — — — — — — — — — — —
Insider Ownership 1.78%

Capital & Financial Ratios $m

Market Cap 448.75
Revenue 519.18
Net Income 24.70
Free Cash Flow 14.64
Net Debt 91.13
Current Ratio 2.12 (at or above 1.5: strong)
Debt/Equity 0.41 (at or below 0.5: strong)
P/E ratio 19.18
Fwd P/E 28.10
P/S ratio 0.88
P/B ratio 1.65
Past 5Y EPS Growth —
This Y EPS Growth (35.90%) (below 0%: weak)
Next Y EPS Growth 50.86% (at or above 15%: strong)
Next Y revenue growth (2.78%) (below 0%: weak)
Next 5Y EPS Growth 8.79%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 7.48%
10-year low 10-year high
P/S against its own 10 years 1.44%
10-year low 10-year high
P/B against its own 10 years 0.31%
10-year low 10-year high
EV/Sales against its own 10 years 1.11%
10-year low 10-year high
EV/FCF against its own 10 years 50.68%
10-year low 10-year high

Dividends

Payout Ratio 0.08
Annual Dividend Rate 0.04
Annual Dividend Yield 0.40%
total individual payouts
2027 Powerpack
2026 0.04
0.01
0.01
0.01
2025 0.04
0.01
0.01
0.01
0.01
2024 0.04
0.01
0.01
0.01
0.01
2023 0.04
0.01
0.01
0.01
0.01
2022 0.04
0.01
0.01
0.01
0.01
2021 0.04
0.01
0.01
0.01
0.01
2020 0.28
0.25
0.01
0.01
0.01
2019 2.20
0.55
0.55
0.55
0.55
2018 2.20
0.55
0.55
0.55
0.55
2017 2.20
0.55
0.55
0.55
0.55
2016 3.30
0.55
0.55
0.55
0.55
0.55
0.55
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 15 19 23 23
Receivables 123 122 121 116
Inventory 72 59 54 58
Other 5 11 7 7
223 221 215 214
2023 2024 2025 Q'26
Payables 34 35 37 40
ST’ Debt — — — —
Other 8 8 17 17
88 102 106 101

Compound Annual Growth %

10y 5y 3y
Sales (4.07%) 1.56% 2.44%
Cash Flow (16.29%) (8.54%) 14.06%
Earnings (12.66%) 0.00% 15.11%
Book Value 0.00% 29.21% 12.94%

Revenue $m

Mar Jun Sep Dec Year
’26 122 125 — — —
’25 124 130 135 138 527
’24 130 131 134 129 524
’23 128 128 125 128 510
’22 115 121 126 128 490
’21 108 119 118 125 470
’20 152 116 105 114 487
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 8 — — —
’25 7 14 9 8 37
’24 6 17 13 21 56
’23 (3) 9 0 19 25
’22 5 1 6 13 25
’21 8 9 12 7 37
’20 22 27 21 (12) 58
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 1 4 — — —
’25 4 11 6 5 25
’24 3 14 11 17 45
’23 (5) 7 (4) 17 15
’22 3 (2) 3 13 17
’21 5 7 9 3 23
’20 19 24 19 (14) 47
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.02) 0.13 — — —
’25 0.00 0.22 0.30 0.11 0.68
’24 0.07 0.19 0.25 0.15 0.66
’23 0.05 0.48 0.19 0.05 0.86
’22 (0.04) 0.15 0.16 0.14 0.42
’21 0.18 0.17 0.02 0.06 0.42
’20 (2.44) (0.13) 0.07 0.30 (2.20)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 84.50 86.55 56.72 36.50 6.68 21.08 13.19 16.69 13.82 9.72

Analyst estimates 2026–2028

Powerpack
High 135.49 125.83 130.34 75.63 41.61 49.87 35.83 27.95 25.13 20.82
People
People Employees 4,400 4,600 4,700 4,300 3,700 3,700 3,600 3,600 3,500 3,300
Revenue/emp, $m 0.13 0.14 0.15 0.16 0.13 0.13 0.14 0.14 0.15 0.16
Income, $m
Income, $m Revenue 590 648 701 668 487 470 490 510 524 527
Gross margin, % 25.88 28.23 29.09 25.83 23.09 21.77 19.62 21.54 19.72 20.69
EBT 76 99 105 82 (91) 36 30 41 46 46
EBT margin, % 12.86 15.32 15.02 12.27 (18.71) 7.68 6.12 8.08 8.82 8.72
Net income 64 81 80 94 (97) 20 20 37 32 30
Depreciation 27 25 23 23 21 19 17 16 15 15
Per share, $
Per share, $ Revenue 13.58 14.67 15.85 15.06 10.96 10.22 10.57 10.92 11.17 11.34
Earnings 1.46 1.88 1.79 2.28 (2.20) 0.42 0.42 0.87 0.66 0.68
Cash flow 3.03 2.81 2.53 2.02 1.30 0.80 0.54 0.53 1.20 0.80
Capex (0.25) (0.42) (0.50) (0.49) (0.24) (0.29) (0.18) (0.21) (0.24) (0.25)
Free cash flow 2.78 2.40 2.03 1.53 1.06 0.51 0.36 0.32 0.96 0.55
Book value 3.57 3.37 3.64 4.11 1.70 3.50 4.08 4.92 5.38 5.86
Shares, m 43 44 44 44 44 46 46 47 47 46
Valuation, ×
Valuation, × P/E 83.36 59.57 33.14 16.52 0.00 51.88 46.56 22.66 26.23 25.03
P/S 8.97 7.63 3.76 2.50 2.42 2.18 1.81 1.60 1.55 1.41
P/B 34.08 33.25 16.39 9.17 15.60 6.38 4.68 3.55 3.22 2.73
EV/Sales 9.31 7.96 4.16 2.96 3.08 2.71 2.28 2.04 1.90 1.72
EV/FCF 45.43 48.74 32.46 29.09 31.76 54.38 67.26 70.42 21.92 35.80
Cash, $m
Cash, $m Operating cash flow 132 124 112 90 58 37 25 25 56 37
Capex (11) (18) (22) (22) (11) (13) (8) (10) (11) (12)
Free cash flow 121 106 90 68 47 23 17 15 45 25
Balance, $m
Balance, $m Working capital 82 107 128 110 76 98 109 135 119 109
Total debt 216 227 290 305 259 189 172 163 126 110
Net debt 202 213 277 294 246 171 157 148 107 88
Shareholders’ equity 155 149 161 182 76 161 189 230 252 272
Returns, %
Returns, % ROA 10.66 14.36 12.89 14.33 (14.54) 3.43 3.36 6.30 5.36 5.08
ROIC 15.31 19.02 16.94 12.69 (14.94) 8.52 7.50 9.04 10.19 9.81
ROE 97.11 54.68 51.37 59.46 (75.77) 16.68 11.12 17.52 13.03 11.31
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Core Laboratories Inc. vs peers in Oil & Gas Equipment & Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
PUMP ProPetro Holding Corp. $975.2M — (loss-making) — (loss-making) −6.24% (below 0%: shrinking) n/m −57.23% (below 0%: shrinking) 23.48% (1.04%) Compare
FTK Flotek Industries, Inc. $895.7M 22.5× 40.7× +70.29% (above 0%: growing) +460.00% (above 0%: growing) −31.76% (below 0%: shrinking) 23.93% 14.98% Compare
FET Forum Energy Technologies, Inc. $884.7M — (loss-making) 27.5× +13.24% (above 0%: growing) +77.42% (above 0%: growing) −35.07% (below 0%: shrinking) 31.54% 9.07% Compare
ACDC ProFrac Holding Corp. $750.4M — (loss-making) — (loss-making) −0.76% (below 0%: shrinking) n/m −114.52% (below 0%: shrinking) 22.08% (7.61%) Compare
OIS Oil States International, Inc. $479.0M — (loss-making) 18.5× −5.29% (below 0%: shrinking) +100.00% (above 0%: growing) −124.96% (below 0%: shrinking) 24.71% 7.48% Compare
CLB Core Laboratories Inc. $448.8M 19.2× 28.1× −4.26% (below 0%: shrinking) −43.48% (below 0%: shrinking) −65.67% (below 0%: shrinking) 18.65% 7.34%
NGS Natural Gas Services Group, Inc. $399.3M 19.1× 19.4× +24.21% (above 0%: growing) −28.57% (below 0%: shrinking) +144.88% (above 0%: growing) 59.94% 19.30% Compare
RNGR Ranger Energy Services, Inc. $337.9M 23.6× 9.2× +25.53% (above 0%: growing) −12.12% (below 0%: shrinking) +33.55% (above 0%: growing) 19.15% 6.69% Compare
SND Smart Sand $214.5M 18.8× 10.4× +34.14% (above 0%: growing) −52.73% (below 0%: shrinking) +80.86% (above 0%: growing) 17.23% 8.74% Compare
Median of peers $614.7M 20.8× 19.0× +18.73% +32.65% −33.41% 23.71% 8.11%

All 46 Oil & Gas Equipment & Services stocks →

Core Laboratories Inc. (CLB) key facts

  • Strength: Core Laboratories Inc.’s revenue for fiscal 2025 (year ended December 2025) was $526.5 million, up 0.51% from fiscal 2024.
  • Core Laboratories Inc. (CLB) is an Oil & Gas Equipment & Services company in the Energy sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, CLB traded at $9.98, a market capitalization of $448.8 million.
  • Core Laboratories Inc. pays an annual dividend of $0.04 per share, a yield of 0.40%, with a payout ratio of 7.68%.
  • Return on equity was 11.3% and debt-to-equity 0.41.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.29 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Core Laboratories Inc. (CLB) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/CLB · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com